| 000 | 01369 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513100112.0 | ||
| 264 | 0 | _c19961113 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a0301-0430 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThompson, C H | |
| 245 | 0 | 0 |
_aSkeletal muscle metabolism before and after gemfibrozil treatment in dialysed patients with chronic renal failure. _h[electronic resource] |
| 260 |
_bClinical nephrology _cJun 1996 |
||
| 300 |
_a386-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 | _aExercise |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGemfibrozil _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperlipidemias _xdrug therapy |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
| 650 | 0 | 4 | _aPeritoneal Dialysis, Continuous Ambulatory |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aIrish, A | |
| 700 | 1 | _aKemp, G J | |
| 700 | 1 | _aTaylor, D J | |
| 700 | 1 | _aRadda, G K | |
| 773 | 0 |
_tClinical nephrology _gvol. 45 _gno. 6 _gp. 386-9 |
|
| 999 |
_c8789652 _d8789652 |
||